Here are four notes:
1. The TIF procedure is designed to help control chronic gastroesophageal reflux disease. The FDA cleared the original EsophyX device in 2007.
2. HCSC’s new medical coverage policy will make the TIF procedure with the EsophyX device available to its approximately 15 million members.
3. HCSC’s network includes Blue Cross Blue Shield associations of Illinois, Montana, New Mexico, Oklahoma and Texas.
4. HCSC’s coverage decision expands on the American Medical Association’s decision earlier this year to create a new Category 1 Current Procedural Terminology code for EGD esophagogastric fundoplasty.
More articles on GI/endoscopy:
AGA, other societies express concerns about alternate payment model adoption to CMS: 4 notes
4 insights on increasing anesthesia use in outpatient GI procedures
GI physician leader to know: Dr. Jeffrey Dunkelberg of University of Iowa Hospitals
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.